Hypothesis

Chronic activation of BAG3-mediated chaperone-assisted selective autophagy (CASA) in aging cells directly consumes NAD+ through PARP-dependent mechanisms, creating a vicious cycle that exacerbates age-related proteostasis collapse and systemic decline. This challenges the view of NAD+ decline as solely maladaptive, proposing it's partly driven by the cell's own adaptive responses to mechanical and proteotoxic stress.

Background and Rationale

Aging is marked by proteostasis failure and NAD+ depletion. BAG3-mediated CASA strengthens with age as an adaptive response to clear damaged proteins the BAG1-to-BAG3 switch, upregulated by Nrf2 Nrf2-driven BAG3 expression. Meanwhile, NAD+ decline is fueled by CD38 upregulation, PARP activity, and reduced biosynthesis drivers of NAD+ loss, impairing sirtuins that regulate autophagy sirtuins and autophagy. While NAD+ restoration reverses aging dysfunction NAD+ precursor benefits, the link between CASA activation and NAD+ consumption remains unexplored. Recent threads on BAG3's mechanical roles suggest it acts as a mechanostat, linking tissue stiffness to cellular responses. I propose that mechanical stress-induced CASA activation chronically engages PARPs, draining NAD+ and turning a protective mechanism into a driver of aging.

Novel Mechanistic Insight

BAG3 is implicated in mechanotransduction, organizing autophagy in response to cellular tension. This mechanical activation might recruit PARP enzymes, which consume NAD+ during stress responses NAD+ and aging hallmarks. In aged tissues, increased stiffness could lead to persistent CASA activation, chronically stimulating PARPs and depleting NAD+. This creates a feedback loop: NAD+ loss reduces sirtuin activity, impairing autophagy regulation and further stressing proteostasis, which boosts CASA demand. Additionally, Nrf2-mediated BAG3 upregulation might cross-talk with NAD+ biosynthetic pathways, potentially suppressing them under prolonged stress. This reframes aging as a trade-off where short-term structural integrity is prioritized over long-term metabolic health, making NAD+ decline a consequence of adaptive ambition, not just a cause of decline.

Testable Predictions

1. Inducing mechanical stress in young cells or tissues should increase BAG3 expression, PARP activity, and NAD+ consumption. Use stretch chambers or substrates of varying stiffness to mimic aging mechanics, measuring NAD+ levels and PARP activation.

2. Genetic knockdown of BAG3 in aged models should attenuate NAD+ depletion. Compare NAD+ levels, sirtuin activity, and proteostasis markers in BAG3-deficient versus wild-type aged mice.

3. PARP inhibition should rescue NAD+ levels without impairing CASA efficiency in aging contexts. Treat stressed cells with PARP inhibitors and assess whether proteostasis is maintained while NAD+ is preserved.

4. Tissue-specific analysis should show higher co-expression of BAG3 and PARP genes in mechanically loaded tissues like muscle or heart, correlating with faster NAD+ decline. Use single-cell sequencing from aged cohorts to map these patterns.

5. Temporal studies tracking BAG3 activation and NAD+ levels during aging should reveal that CASA precedes or coincides with NAD+ drop. Longitudinal monitoring in model organisms like C. elegans or mice.

Implications

If validated, targeting the BAG3-PARP axis could decouple adaptive proteostasis from metabolic drain, extending healthspan beyond simple NAD+ supplementation. This integrates mechanotransduction with metabolic aging, suggesting combination therapies that modulate stress responses. It also offers a new lens for tissue-specific aging, where mechanical load dictates metabolic decline via BAG3-driven NAD+ consumption.